文献速递肝病消化道肿瘤与早癌

长读长RNA测序识别肝细胞癌中的可变剪接变体及肿瘤特异性同工型

Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.
PubMed 文献 · Hepatology · 2019-03-22

研究采用单分子实时长读长RNA测序分析患者来源的肝细胞癌(HCC)细胞,获得HCC可变剪接全景图并发现362个既往数据库未报道的变体。在独立原发HCC肿瘤及配对非肿瘤肝组织中验证了许多变体为肿瘤特异性,并聚焦ARHGEF2变体(v1和v3)的功能研究,显示其与癌症干性和上皮间质转化介导的侵袭迁移相关,v3较v1作用更强。

要点

  • 长读长RNA测序在HCC中鉴定出362个既往未报道的可变剪接变体。
  • 许多未注释和已注释变体在原发HCC肿瘤中为肿瘤特异性。
  • ARHGEF2变体v1和v3与癌症干性及上皮间质转化相关,v3较v1作用更强。

核心结论

  • 由异常剪接产生的可变同工型和肿瘤特异性同工型在肝肿瘤发生中常见。
  • 长读长RNA测序分析为HCC可变剪接提供了新见解。

研究设计与样本

  • 对患者来源的HCC细胞进行单分子实时长读长RNA测序,使用SpliceMap-LSC-IDP算法定义剪接连接。
  • 在独立原发HCC肿瘤及配对非肿瘤肝组织队列中验证变体。
  • 采用Sanger测序联合TaqMan连接检测法确定剪接变体的表达。

主要发现

  • 发现362个既往任何数据库(RefSeq和GENCODE)均未报道的可变剪接变体,主要源于内含子保留和提前终止密码子,其中81.5%具有框内开放阅读框。
  • 在独立原发HCC肿瘤及配对非肿瘤肝组织中验证了许多预测的未注释和已注释变体为肿瘤特异性。
  • 确定了酶调节因子(ARHGEF2、SERPINH1)、染色质修饰因子(DEK、CDK9、RBBP7)、RNA结合蛋白(SRSF3、RBM27、MATR3、YBX1)和受体(ADRM1、CD44v8-10、维生素D受体、ROR1)剪接变体在HCC肿瘤中的独特和共同表达。
  • 针对源于HCC常见扩增位点chr.1q22的ARHGEF2变体(v1和v3)的功能研究显示其与癌症干性和上皮间质转化介导的细胞侵袭迁移相关,v3始终比v1作用更强。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alternative splicing (AS) allows generation of cell type-specific mRNA transcripts and contributes to hallmarks of cancer. Genome-wide analysis for AS in human hepatocellular carcinoma (HCC), however, is limited. We sought to obtain a comprehensive AS landscape in HCC and define tumor-associated variants. Single-molecule real-time long-read RNA sequencing was performed on patient-derived HCC cells, and presence of splice junctions was defined by SpliceMap-LSC-IDP algorithm. We obtained an all-inclusive map of annotated AS variants and further discovered 362 alternative spliced variants that are not previously reported in any database (neither RefSeq nor GENCODE). They were mostly derived from intron retention and early termination codon with an in-frame open reading frame in 81.5%. We corroborated many of these predicted unannotated and annotated variants to be tumor specific in an independent cohort of primary HCC tumors and matching nontumoral liver. Using the combined Sanger sequencing and TaqMan junction assays, unique and common expressions of spliced variants including enzyme regulators (ARHGEF2, SERPINH1), chromatin modifiers (DEK, CDK9, RBBP7), RNA-binding proteins (SRSF3, RBM27, MATR3, YBX1), and receptors (ADRM1, CD44v8-10, vitamin D receptor, ROR1) were determined in HCC tumors. We further focused functional investigations on ARHGEF2 variants (v1 and v3) that arise from the common amplified site chr.1q22 of HCC. Their biological significance underscores two major cancer hallmarks, namely cancer stemness and epithelial-to-mesenchymal transition-mediated cell invasion and migration, although v3 is consistently more potent than v1. Conclusion: Alternative isoforms and tumor-specific isoforms that arise from aberrant splicing are common during the liver tumorigenesis. Our results highlight insights gained from the analysis of AS in HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Chen H, Gao F, He M, et al. Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms. Hepatology. 2019. PMID: 30637779. doi:10.1002/hep.30500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。